| Issue |
Med Sci (Paris)
Volume 29, Number 2, Février 2013
|
|
|---|---|---|
| Page(s) | 133 - 135 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2013292006 | |
| Published online | 28 February 2013 | |
Un trio de choc pour pallier la chimiorésistance des cancers : c-MYC, PARP1, BIN1
c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistance
1
Molecular signaling program, Stanley S. Scott cancer center, Louisiana state university, Health sciences center, New Orleans, Louisiana 70112, États-Unis
2
Institut de génétique moléculaire, cibles thérapeutiques, Inserm U940, 27, rue Juliette Dodu, 75010 Paris, France
3
Department of biochemistry and molecular biology, GHSU cancer center, Georgia health sciences university, Augusta, Georgia 30912, États-Unis
Cet article ne possède pas de résumé.
© 2013 médecine/sciences – Inserm / SRMS
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
